Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms

被引:54
|
作者
Cocuaud, C [1 ]
Rodier, MH [1 ]
Daniault, G [1 ]
Imbert, C [1 ]
机构
[1] CHU La Miletrie, Lab Parasitol & Mycol Med, F-86021 Poitiers, France
关键词
candidiasis; catheters; antifungals; metabolism; echinocandins;
D O I
10.1093/jac/dki269
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Candidiasis can be associated with the formation of biofilms on bioprosthetic surfaces and the intrinsic resistance of Candida albicans biofilms to the most commonly used antifungal agents has been demonstrated. In this study, we report on the antifungal activity of caspofungin at two different concentrations, on C. albicans and Candida parapsilosis biofilms with different ages of maturation. Methods: Fifteen strains of C. albicans (10 strains susceptible to fluconazole in vitro and five strains resistant to this antifungal agent) and six strains of C. parapsilosis (all were susceptible to fluconazole in vitro) were studied. The antifungal activity of caspofungin was assessed by looking for a significant inhibition of the metabolic activity of yeasts within biofilms. Biofilms of Candida were produced in vitro, on silicone catheters. Results: Caspofungin used at MIC did not modify the metabolic activity of C. albicans, whatever the maturation age of the biofilms. The same concentration of caspofungin significantly reduced the metabolism (P <= 0.001) of 25% (biofilms of 48 h) to 50% (biofilms of 2 h) of the C. parapsilosis yeasts. The use of a therapeutic concentration of caspofungin (2 mg/L) significantly decreased (P <= 0.001) the metabolism of all the strains of C. albicans and C. parapsilosis tested, independently of the biofilm maturation age. This potent antifungal activity of caspofungin on C. albicans biofilms was observed independently of the yeast susceptibility to fluconazole. Conclusions: This study demonstrated that caspofungin used at MIC was not sufficient to reduce C. albicans biofilms, but it suggested an activity on C. parapsilosis biofilms depending on their maturation age. This study also indicated that caspofungin used at 2 mg/L could be a good candidate in the prevention of candidiasis associated with silicone medical devices. Our results also suggested that fluconazole resistance of yeasts did not affect caspofungin activity.
引用
下载
收藏
页码:507 / 512
页数:6
相关论文
共 50 条
  • [21] Antifungal activity of functionalized carbon nanotubes conjugated to Amphotericin-B against Candida albicans and Candida parapsilosis biofilms
    Vikelouda, A.
    Simitsopoulou, M.
    Kechagioglou, P.
    Papi, R.
    Kyriakidis, D.
    Roilides, E.
    MYCOSES, 2017, 60 : 85 - 85
  • [22] The Nonsteroidal Antiinflammatory Drug Diclofenac Potentiates the In Vivo Activity of Caspofungin Against Candida albicans Biofilms
    Bink, Anna
    Kucharikova, Sona
    Neirinck, Bram
    Vleugels, Jef
    Van Dijck, Patrick
    Cammue, Bruno P. A.
    Thevissen, Karin
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (11): : 1790 - 1797
  • [23] In Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
    Sarkar, Semanti
    Uppuluri, Priya
    Pierce, Christopher G.
    Lopez-Ribot, Jose L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1183 - 1186
  • [24] INFLUENCE OF PH ON KETOCONAZOLE ACTIVITY AGAINST CANDIDA-PARAPSILOSIS AND CANDIDA-ALBICANS
    BEGGS, WH
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1982, 37 (03): : 495 - 498
  • [25] Micafungin is more active against Candida albicans biofilms with high metabolic activity
    Judith Marcos-Zambrano, Laura
    Escribano, Pilar
    Gonzalez del Vecchio, Marcela
    Bouza, Emilio
    Guinea, Jesus
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (11) : 2984 - 2987
  • [26] In vitro activity of eugenol against Candida albicans biofilms
    Miao He
    Minquan Du
    Mingwen Fan
    Zhuan Bian
    Mycopathologia, 2007, 163 : 137 - 143
  • [27] In vitro activity of baicalein against Candida albicans biofilms
    Cao, YingYing
    Dai, BaoDi
    Wang, Yan
    Huang, Shan
    Xu, YongGang
    Cao, YongBing
    Gao, PingHui
    Zhu, ZhenYu
    Jiang, YuanYing
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (01) : 73 - 77
  • [28] Caspofungin in combination with amphotericin B against Candida parapsilosis
    Barchiesi, Francesco
    Spreghini, Elisabetta
    Tornassetti, Serena
    Giannini, Daniele
    Scalise, Giorgio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) : 941 - 945
  • [29] Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates
    Shirazi, F.
    Kontoyiannis, D. P.
    VIRULENCE, 2015, 6 (04) : 385 - 394
  • [30] In vitro activity of anidulafungin against Candida albicans biofilms
    Jacobson, Melissa J.
    Piper, Kerryl E.
    Nguyen, Gary
    Steckelberg, James M.
    Patel, Robin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) : 2242 - 2243